FSCN1 and liver cancer: However, existing studies have not clarified whether there are differences in the expression of FSCN1 in different histological types of liver cancer, as well as its relationship with clinicopathologic characteristics such as clinical staging, histological differentiation, vascular invasion, presence of hepatitis B and cirrhosis.